Prashanthi Vemuri (@prashvemuri) 's Twitter Profile
Prashanthi Vemuri

@prashvemuri

Professor/Imaging Researcher, Biomarkers, Reserve, and Resilience in Alzheimer's Disease and Cerebrovascular Disease @MayoClinic. Views solely mine !

ID: 447481292

calendar_today26-12-2011 23:18:48

369 Tweet

519 Followers

171 Following

Brain (@brain1878) 's Twitter Profile Photo

Ramanan et al. report that integrating genetic risk scores enhances the diagnostic utility of plasma biomarkers for Alzheimer's disease, including by improving prediction of amyloid PET positivity based on elevated plasma p-tau181. tinyurl.com/42hfukwu

Ramanan et al. report that integrating genetic risk scores enhances the diagnostic utility of plasma biomarkers for Alzheimer's disease, including by improving prediction of amyloid PET positivity based on elevated plasma p-tau181. tinyurl.com/42hfukwu
Prashanthi Vemuri (@prashvemuri) 's Twitter Profile Photo

Looking to recruit a postdoctoral fellow/research scientist to work on a highly translational project with wide impact! If you are at #AAIC2023 and would like to learn more, please DM me.

Mayo Clinic Neurology Residency (@mayoneurores) 's Twitter Profile Photo

#ScholarlySundays Congratulations to Dr. Cam Bermudez, MD, PhD (PGY3) on his recent publication, "Plasma biomarkers for prediction of Alzheimer’s disease neuropathologic change" tinyurl.com/jfr7wktb #MayoNeuroResidency

#ScholarlySundays Congratulations to Dr. <a href="/bermudezcamilo/">Cam Bermudez, MD, PhD</a> (PGY3) on his recent publication, "Plasma biomarkers for prediction of Alzheimer’s disease neuropathologic change" tinyurl.com/jfr7wktb #MayoNeuroResidency
Christopher G. Schwarz (@chrisgschwarz) 's Twitter Profile Photo

New in Editorial team - Neuroimage Clinical: We compared correlations between AD imaging biomarkers and cognition, using unmodified images vs. images de-faced with mri_reface. All of the de-faced analyses were statistically identical both qualitatively and in statistical power. authors.elsevier.com/sd/article/S22…

Prashanthi Vemuri (@prashvemuri) 's Twitter Profile Photo

Excited about our new work led by @RobelKGebre with great colloboration with Alexis Moscoso Rial; Michael Schöll : "Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measure" researchsquare.com/article/rs-329…

Lyell Jones MD (@lyellj) 's Twitter Profile Photo

Are anti-amyloid monoclonals for Alzheimer disease going to overwhelm neurology access? Crush health system finances? Applying trial criteria to a population of MCI/mild-AD patients, <10% of patients would receive these drugs. Excellent infographic here from Neurology Journal ⬇️

Are anti-amyloid monoclonals for Alzheimer disease going to overwhelm neurology access? Crush health system finances?

Applying trial criteria to a population of MCI/mild-AD patients, &lt;10% of patients would receive these drugs. Excellent infographic here from <a href="/GreenJournal/">Neurology Journal</a> ⬇️
Paul Thompson (@ptenigma) 's Twitter Profile Photo

Impressive new guided tour of the brain imaging analysis toolbox, CAT12 - by @ChristianGaser + Team 🧠🧠 ! 👉biorxiv.org/content/10.110…

Impressive new guided tour of the brain imaging analysis toolbox, CAT12 -  by @ChristianGaser + Team 🧠🧠 !  👉biorxiv.org/content/10.110…
DISCOVERY Study (@discoverystudy) 's Twitter Profile Photo

📣 Today is the day we’ve been waiting for 🎉🎉🎉 We are thrilled to announce 2️⃣5️⃣0️⃣0️⃣ DISCOVERY Study enrollments 🙌🎉💯 Another momentous milestone 👏 Big CONGRATS & THANKS to all our study personnel, our participants & their families - now, onto the new heights 🏔️ 🚀💯🧠

📣 Today is the day we’ve been waiting for 🎉🎉🎉 

We are thrilled to announce 2️⃣5️⃣0️⃣0️⃣ <a href="/DiscoveryStudy/">DISCOVERY Study</a> enrollments 🙌🎉💯 

Another momentous milestone 👏

Big CONGRATS &amp; THANKS to all our study personnel, our participants &amp; their families - now, onto the new heights 🏔️ 🚀💯🧠
Mayo Clinic Neuro (@mayoclinicneuro) 's Twitter Profile Photo

The Mayo Clinic Department of Neuroscience is recruiting an outstanding investigator (MD or MD/PhD or equivalent) with neuropathology training and expertise in aging and neurodegenerative disorders. Learn more and apply: mayocl.in/48mcJE8 #NeuroTwitter